NCT05696704 · Texas Tech University
Telehealth to Reduce Mental Health in Family Caregivers
What this study is about
The overarching goal of this project is to evaluate if evidence-based interventions can reduce PDG, burden, and stress in informal caregivers of individuals with dementia when provided over telehealth.
View original scientific description
The overarching goal of this project is to evaluate if evidence-based interventions can reduce PDG, burden, and stress in informal caregivers of individuals with dementia when provided over telehealth.
Interventions
OTHER
Behavioral: Mindfulness Based Cognitive Therapy
Individual tele-therapy 12 to 16 weeks
OTHER
Behavioral: Behavior Activation
Individual therapy 12 to 16 weeks
Primary outcome measures
Prolonged Grief Scale-12 (measuring pre-death grief)
Time frame: [Time Frame: through study completion, an average of 6 months]
The PG-12 (range 11-55; higher scores mean higher pre-death grief), which is used to measure pre-death grief will be used to measure grief of having a loved one live with a life limiting illness and no longer be able to engage in valued activities.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Participants must be informal caregivers (e.g., spouse; child; close friend) of individuals with dementia
- Informal caregivers can be family members or close friends
- Adults (18 to 89 years old) who read, write, and speak in English
- Mental Health Diagnosis (e.g., Generalized Anxiety Disorder; Major Depressive Disorder
Exclusion criteria
- Formal caregivers (who are being paid to take care of the patient)
- Any informal caregivers with cognitive impairment is identified during the assessment.
Where
- Lubbock, Texas
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 15, 2026 · Source of record for eligibility and locations